Get the SPI Wire

Tempest Therapeutics, Inc.

NASDAQ:TPST
Annual Meeting

of Shareholders

MEETING DATE

07/27/2026
DEF 14A FILED
07/17/2026
PUBLISHED
07/17/2026 8:32 pm
TIME TO PUBLISH
07/19/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:TPST · CUSIP 87990A106 · CIK 0001544227

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

1
FOR
0
AGAINST
0
WITHHOLD
1
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Approval of a Certificate of Amendment to the Company's Restated Certificate of Incorporation to replace specified supermajority voting requirements and permit stockholder action by written consent
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states amendment permits stockholder action by written consent and replaces specified supermajority voting provisions.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates